These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32330528)

  • 1. The Impact of Alternative Alkalinizing Agents on 24-Hour Urine Parameters.
    Boydston K; Terry R; Winship B; Davis L; Yttri S; Carlos E; Scales C; Lipkin M; Preminger GM
    Urology; 2020 Aug; 142():55-59. PubMed ID: 32330528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial.
    Mechlin C; Kalorin C; Asplin J; White M
    J Endourol; 2011 Sep; 25(9):1541-5. PubMed ID: 21815827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tolerability of Potassium Citrate Tablet in patients with intolerance to Potassium Citrate Powder form.
    Basiri A; Taheri F; Taheri M
    Urol J; 2018 Jan; 15(1):16-20. PubMed ID: 29363092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of renal lithiasis with potassium citrate.
    Spivacow FR; Negri AL; Polonsky A; Del Valle EE
    Urology; 2010 Dec; 76(6):1346-9. PubMed ID: 20399488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
    Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
    J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkalinizing Agents: A Review of Prescription, Over-the-Counter, and Medical Food Supplements.
    Stern KL; Canvasser N; Borofsky M; Gleason VM; Kamphuis G; El Tayeb MM; Hsi R; Scotland KB
    J Endourol; 2020 Jan; 34(1):1-6. PubMed ID: 31333065
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia.
    Jhagroo RA; Wertheim ML; Penniston KL
    Br J Clin Pharmacol; 2016 Jan; 81(1):131-6. PubMed ID: 26297809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.
    Tosukhowong P; Yachantha C; Sasivongsbhakdi T; Ratchanon S; Chaisawasdi S; Boonla C; Tungsanga K
    Urol Res; 2008 Aug; 36(3-4):149-55. PubMed ID: 18560820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
    Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
    J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
    Kang DE; Sur RL; Haleblian GE; Fitzsimons NJ; Borawski KM; Preminger GM
    J Urol; 2007 Apr; 177(4):1358-62; discussion 1362; quiz 1591. PubMed ID: 17382731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formers.
    Wollin DA; Davis LG; Winship BB; Carlos EC; Tom WR; Asplin JR; Kosinski AS; Scales CD; Ferrandino MN; Preminger GM; Lipkin ME
    Urolithiasis; 2020 Apr; 48(2):131-136. PubMed ID: 31062069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
    Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
    J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.